Literature DB >> 2530875

A four-week double-blind, placebo-controlled, parallel dose-response study of amlodipine in patients with stable exertional angina pectoris.

S H Taylor1, P Lee, N Jackson, G Cocco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2530875     DOI： 10.1016/0002-8703(89)90845-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  4 in total

Review 1.  Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.

Authors:  D Murdoch; R C Heel
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

Review 2.  Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease.

Authors:  M Haria; A J Wagstaff
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

3.  Antianginal effects of amlodipine at a single dose on exertional angina patients using treadmill exercise testing--a randomized crossover study in comparison with placebo.

Authors:  H Kishida; N Hata; T Kunimi; H Miyagawa; H Nishiyama; K Katoh
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

4.  Efficacy of amlodipine besilate therapy for variant angina: evaluation by 24-hour Holter monitoring.

Authors:  K Watanabe; T Izumi; Y Miyakita; S Koyama; M Ohshima; T Inomata; M Suzuki; M Takahashi; A Shibata
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.